Member Info for sheps85

sorry about that double message, mistake on my part

Rambler has had this gold mine for quite a few years and everyone knows what it has. I bought it numerous years ago and it never went anywhere and has slowly fallen to the lowest price it is now at. Why do you think anything is going to change now and that the share price is going to fly. Personally i think it is a dog share you have bought, but wish you luck.

Rambler has had this gold mine for quite a few years and everyone knows what it has. I bought it numerous years ago and it never went anywhere and has slowly fallen to the lowest price it is now at. Why do you think anything is going to change now and that the share price is going to fly. Personally i think it is a dog share you have bought, but wish you luck.

nice to see share talks new info, plotting the chart to rise to 50p by end of the month. fingers crossed

How much longer do we need to wait for some action here, very tedious.

witness the highest CAGR of 13.88% during the forecast period, 2020-2030."
Request for a Sample: Global Oncology Precision Medicine Market
Key insights have been drawn from in-depth interviews with the key opinion leaders of more than 50 leading companies, market participants, and vendors. The key players profiled in the report include Abbott Laboratories, Agilent Technologies, Inc., Almac Group Ltd., ANGLE plc, Asuragen, Inc., Bristol Myers Squibb, bioMérieux SA., BGI Group, Bio-Rad Laboratories, Inc F. Hoffmann-La Roche AG, Gilead Sciences, Inc. Illumina, Inc, Konica Minolta, Inc., Laboratory Corporation of America Holdings, MDx Health, Inc., Myriad Genetics, Inc., Novartis AG, Opko Health, Inc., Pacific Biosciences of California, Inc., Thermofisher Scientific, QIAGEN N.V., and Quest Diagnostics.

Sorry if this has been mentioned already, Angle has been mentioned in the following web site for one company that is being monitored, in the precision medicine market

https://bisresearch.com/industry-report/non-oncology-precision-medicine-market.html

St Fort sur Gironde in the hamlet behind the dechetterrie, code - 042956

Yes I know it, about 8minutes away. Will work something out when you get back and settled. Take care. see you soon.

Fc I would like to meet, let me know if you are interested. I live just up the road from mirambeau.

Thanks for your unfriendly comment, I will likewise without an apology. My 1.8mill shares at 1.6p tend to make me resilient to your, for your information calling someone a burke is an endearment in my book and not an insult.

Your calculations come to 10.5 billion, you burke

we will have to meet up in mirambeau for a coffee

Why does anyone need to be looking at any other share than THE BEST ONE, GREATLAND GOLD beats me why.

Brilliant bit of poetry Joe, I can see gervaise copying that and putting it up in his office.

I still think they borrowed shares to fill that 127 million order, and are now struggling to get them back before news hits. this is why it is being worked down to fish out more shares from the weak. news and if it is good up we will go.

fc1865, I know mirambeau my dentists there and go shopping at the super u. I live up the road in St Fort sur Gironde, have for 17yrs now, in a little hamlet just behind the dechetterie.(Chez Grenier) Small world

Does anyone else think that the mm's might have borrowed shares in order to fill that 137million share order at 27p. Now they are holding it under 24p so that they can use the sellers to pay it back at a lower price. which makes it feel like there is an overhang. It just seems strange movement on the price at the moment. Seems it is certainly being held back. We have had more of sells recently, than buys but it has still been held around the same price. conspiracy wise thats why the scally results might be held back until they balance the books again. Or might be my suspicious mind, any thoughts

that should read 750K salary

well done paddy, all these traders selling today they haven't got a clue about investing. This whole area is a world find. Bring in the champagne.